Cheng-Hao Tseng

24PUBLICATIONS
114CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)PharmacogenomicsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 03, 2026
Impact of Baseline Synchronous Adenoma Burden on the Risk of Metachronous Advanced Neoplasia.

|Jul 10, 2026
Comparative Effectiveness and Safety of Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab as First-Line Systemic Therapy for Hepatocellular Carcinoma: A Real-World Study.

|Jun 14, 2026
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

|May 21, 2026
Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B.

|Apr 07, 2026
Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss.

Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng

|Mar 10, 2026
Cold Snare Polypectomy and Cold Endoscopic Mucosal Resection Versus Hot Endoscopic Mucosal Resection for Intermediate-Size Sessile Serrated Lesions: A Randomized Controlled Trial.

Li-Chun Chang, Andrew Y Wang, Cheng-Hao Tseng

Pageof 4

Frequent Collaborators

11 joint publications

Mindie Nguyen

10 joint publications

Yao-Chun Hsu

6 joint publications

Ming-Lung Yu

6 joint publications

Hidenori Toyoda